MICHAEL BISHAI: Open Payments
NPI 1942409891 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 5 payments from 4 companies in 2025. Trend: 2023 $171 · 2024 $170 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $146 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: AVYCAZ, REXULTI, TEFLARO, ERLEADA, JARDIANCE.
Industry payments across NY — which companies pay providers there.
